 |
인쇄하기
취소
|
CTC Bio wins patent lawsuit
The landscape of the nation’s pharmaceutical market is expected to change as CTC Bio has won a patent suit against Daiichi Sankyo.
CTC Bio said on Feb. 28 that the company was successful in its legal battle against Daiichi Sankyo, citing a decision by the Korea Intellectual Property Tribunal (KIPO) to reject Daiichi Sankyo’s Olmetec patent.
Developed by Sankyo, Olmetec is a selective AT1 ...
CTC Bio said on Feb. 28 that the company was successful in its legal battle against Daiichi Sankyo, citing a decision by the Korea Intellectual Property Tribunal (KIPO) to reject Daiichi Sankyo’s Olmetec patent.
Developed by Sankyo, Olmetec is a selective AT1 ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.